Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database

被引:22
作者
Bromley, SE [1 ]
de Vries, CS [1 ]
Farmer, RDT [1 ]
机构
[1] Univ Surrey, Pharmacoepidemiol Unit, Postgrad Med Sch, Guildford GU2 7DJ, Surrey, England
关键词
D O I
10.1111/j.1471-0528.2004.00082.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To determine prevalence and patterns of hormone replacement therapy (HRT) utilisation in women in the UK. Design Prospective observational study. Setting UK general practice. Population Women from general practices throughout the UK. Methods The study period was I January 1992 to 31 December 1998. Age-specific prevalence was calculated for each year. Trends in prescribing patterns were described over time. A sub-cohort of 'new starters' on HRT was identified to establish patterns of use, including duration of use and switching of preparations. Characteristics of the sub-cohort were compared with a reference group of non-HRT users. Main outcome measures Prevalence, prescribing patterns and differences in characteristics between HRT users and non-HRT users. Results Among women aged 45-64, prevalence of HRT use increased from 18.6% in 1992 to 27.7% in 1998. Secular trends were observed away from prescribing combined-sequential preparations and towards use of combined-continuous preparations. Among the prescriptions for combined HRT products, only 4.3% contained medroxyprogesterone acetate (MPA). A total of 45.7% of women without a record of a hysterectomy and 53.8% of women with a record of a hysterectomy used HRT for at least three years. When women were partitioned by year of starting HRT, there was a trend-of increasing duration of use across the seven years. Some women without a record of a hysterectomy were receiving unopposed oestrogen without progestogen supplementation. Conclusions Within the past decade, use of HRT has increased among women in the UK with large numbers of women using HRT for long periods and treatment often tailored to the individual.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 28 条
[1]   Tibolone: a review [J].
Albertazzi, P ;
Di Micco, R ;
Zanardi, E .
MATURITAS, 1998, 30 (03) :295-305
[2]  
[Anonymous], 1994, Pharmacoepidemiology) and Drug Safety
[3]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[4]  
*BRIT MED ASS ROY, 2001, 42 BMA PHARM SOC GRE
[5]   HRT - DEVELOPMENTS IN THERAPY [J].
ELLERINGTON, MC ;
WHITCROFT, SIJ ;
WHITEHEAD, MI .
BRITISH MEDICAL BULLETIN, 1992, 48 (02) :401-425
[6]   Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Grady, D ;
Herrington, D ;
Bittner, V ;
Blumenthal, R ;
Davidson, M ;
Hlatky, M ;
Hsia, J ;
Hulley, S ;
Herd, A ;
Khan, S ;
Newby, LK ;
Waters, D ;
Vittinghoff, E ;
Wenger, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57
[7]   HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CANCER RISK - A METAANALYSIS [J].
GRADY, D ;
GEBRETSADIK, T ;
KERLIKOWSKE, K ;
ERNSTER, V ;
PETITTI, D .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (02) :304-313
[8]   Postmenopausal hormone therapy for prevention of fractures - How good is the evidence? [J].
Grady, D ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2909-2910
[9]   Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis [J].
Grodstein, F ;
Newcomb, PA ;
Stampfer, MJ .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :574-582
[10]   Ethnic differences in use of hormone replacement therapy: community based survey [J].
Harris, TJ ;
Cook, DG ;
Wicks, PD ;
Cappuccio, FP .
BRITISH MEDICAL JOURNAL, 1999, 319 (7210) :610-611